Kalbe Farma Indonesia are a leading pharmaceutical company.
With variety of innovative products, solid marketing strategy, committed research and development and reliable human resource, the company has established its position as a prominent and well respected player both in local and global market.
We believe in delivering the best to our customers, encouraging our people to strive for excellence and continuous challenge themselves to make improvement, agile and supporting each other and most of all, we believe in integrity as our foundation for success.
Kalbe is rapidly making the transition from being a producer of pharmaceutical, health food and packaging products for the Indonesian market to being a global provider of a full range of products and value-added services that assist consumers around the world to achieve a higher quality of life. Given theenvironment in which the Company operates, this evolution is not only desirable, it is essential.
Normally, the pharmaceutical market in Indonesia grows at2 - 3 times the rate of GDP growth. In 2005, factors such as reduced consumer purchasing power, high inflation rates and the depreciation in the value of the Rupiah contributed to the fact that the industry grew at a slightly slower rate than in previous years, expanding at the rate of 13.5% to a total value of Rp. 23.608 trillion.
It should be noted that while the majority of raw materials for the industry are imported, and therefore vulnerable to effects of depreciation in the value of the Rupiah, the ability of the pharmaceuticals industry to increase the price of its products is constrained by consumers’ ability to pay. Therefore, price increases are usually less than the inflation rate. With the depreciation in the value of the Rupiah against US Dollar over 2005 of 5.81%, from Rp. 9,290 at the end of 2004 to Rp. 9,830 at the end of 2005, and an inflation rate of 17.11%, the competitive pressures on players in the pharmaceutical industry were considerable.
On the other hand, there were a number of positive developments affecting the industry as a whole. In early 2005, the Indonesian Government implemented a policy to extend medical, work-related accident, pension and life insurance coverage to all Indonesians through the National Social Security System. This will improve the health and well-being of Indonesian consumers by providing increased access to necessary treatments, including a full range of pharmaceutical products.
The Government also conducted a review on the pricing policies for essential drugs and branded generics. In the face of challenging circumstances, Kalbe recorded excellent performance in 2005, with revenues from sales reaching Rp. 5.87 trillion, representing an increase of 16.42% over the previous year, when the figure stood at Rp. 5.04 trillion.
Net income reached Rp. 653.33 billion in year 2005 and Rp. 450.70 billion in year 2004, or an increase of 44.96%.
Throughout the year, Kalbe took a number of significant steps to ensure that the Company will remain competitive and profitable in the evolving environment in which it operates.
Most significantly, on December 16, 2005, the management of Kalbe effected the merger of Dankos and Enseval into the company to create the largest publicly listed pharmaceutical company in Southeast Asia.
Kalbe continued to enter into strategic alliances with international partners to facilitate its ability to offer an expanded range of increasingly complex and valuable products to its consumers. In addition, it has made significant steps towards its goal of becoming an innovator and creator of new products which it can produce directly or license to third parties, both through co-development programs and on its own initiative.
We will review your application and if you meet our qualification, we will invite you to join our selection process. We look forward to receiving your application.
Internal Audit Officer (Corp)
Department : Audit
Expire : Thu, Mar 31, 2011
• Age max 30
• Bachelor degree in Accounting from reputable university
• Having min 1 year experience in audit field work / risk management / IT Audit will be a distinct advantage
Product Manager (VSN)
Department : Kalbe Vision
Expire : Thu, Mar 31, 2011
• Age Max 40
• Bachelor degree of Pharmacy / Medical Science
• Having min 1 year experience in managerial level on ethical products
• Good understanding of optha products
IT Officer - Database Administrator
Department: IT
Expire : Thu, Mar 31, 2011
• Age max 30
• Experienced in handling SQL, Oracle, Essbase & Sybase Database
• Good analytical skill
IT Officer - Technical Support
Department : IT
Expire : Thu, Mar 31, 2011
• Age max 30
• Min 1 year experience in similar position
• Willing to be located at Cikarang
IT Officer - Oracle Analyst
Department : IT
Expire : Thu, Mar 31, 2011
• Age max 30
• Good understanding of Oracle Application & Oracle E'Business Suite
• Fluent in TOAD
• Willing to be located at Cikarang
IT Officer - Orlansoft Analyst
Department : IT
Expire : Thu, Mar 31, 2011
• Age max 30
• Fluent in handling Orlansoft Application
• Good analytical skill
• Willing to be located at Cikarang
IT Officer - Hyperion Analyst
Department : IT
Expire : Thu, Mar 31, 2011
• Age max 30
• Good understanding of Essbase scripting, Hyperion financial reporting & Hyperion shared service
• Good analytical skill
Programmer
Department : IT
Expire : Thu, Mar 31, 2011
• Age max 30
• Min 1 year experience as Programmer
• Good analytical skill
Management System Specialist (Corp)
Department : Management System
Expire : Thu, Mar 31, 2011
IT Officer - Database & Business Intelligence
Department : IT
Expire : Thu, Mar 31, 2011
• Age max 30
• Fluent in SQL/Proclarity/Hyperion/BIEE Oracle Business Intelligence
• Min 2 years experience in handling Business Intelligence
Industrial Relation Officer (Corp)
Department : Industrial Relation
Expire : Thu, Mar 31, 2011
• Age max. 30
• Min. bachelor degree in Law
• Min. 1 year exp in industrial relation
Medical Representative (Eth)
Department : Ethical
Expire : Wed, May 18, 2011
Qualified candidates please send your detailed resume to recruitment.corp@kalbe.co.id (please mention position code as email subject) or send to (code : position code) to :
Recruitment Corporate
PT. Kalbe Farma, Tbk
Jl. Letjen Suprapto Kav 4
Jakarta 10510
PO Box 3105 JAK
Source : Lowongan Kerja LKITku.com
